European Growth Stocks Insiders Are Eager To Hold

As European markets navigate the challenges of fresh U.S. trade tariffs and a mixed economic outlook, investors are increasingly focusing on companies that demonstrate resilience and potential for growth. In this environment, stocks with high insider ownership can be particularly appealing, as they often signal confidence from those closest to the company's operations and strategy.

Top 10 Growth Companies With High Insider Ownership In Europe

Click here to see the full list of 239 stocks from our Fast Growing European Companies With High Insider Ownership screener.

Let's uncover some gems from our specialized screener.

Admicom Oyj (HLSE:ADMCM)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Admicom Oyj provides cloud-based software and business process automation solutions in Finland, with a market cap of €267.77 million.

Operations: The company's revenue is primarily derived from its Software & Programming segment, which generated €35.57 million.

Insider Ownership: 21.9%

Admicom Oyj demonstrates strong growth potential with earnings projected to increase by 24.6% annually, outpacing the Finnish market's average. Despite a slight decline in net income recently (€5.87 million from €6.32 million), revenue continues to grow, reaching €35.57 million last year. The company trades at 27.5% below its estimated fair value, suggesting potential undervaluation, while maintaining high insider ownership and a robust forecasted return on equity of 30.2%.

• Click here and access our complete growth analysis report to understand the dynamics of Admicom Oyj.
• In light of our recent valuation report, it seems possible that Admicom Oyj is trading beyond its estimated value.

Pexip Holding (OB:PEXIP)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Pexip Holding ASA is a video technology company that offers a comprehensive video conferencing platform and digital infrastructure globally, with a market cap of NOK4.06 billion.

Operations: The company's revenue primarily comes from the Sale of Collaboration Services, amounting to NOK1.12 billion.

Insider Ownership: 19.6%

Pexip Holding's earnings are set to grow 30% annually, outpacing the Norwegian market. Despite no substantial insider buying recently, insiders have bought more shares than they've sold over three months. Pexip trades at 66.9% below its estimated fair value and has become profitable this year, with sales reaching NOK 1.12 billion in 2024. However, its dividend yield of 6.25% is not well covered by earnings or free cash flows.

• Click here to discover the nuances of Pexip Holding with our detailed analytical future growth report.
• In light of our recent valuation report, it seems possible that Pexip Holding is trading behind its estimated value.

Formycon (XTRA:FYB)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Formycon AG is a biotechnology company that develops biosimilar drugs in Germany and Switzerland, with a market cap of €419.35 million.

Operations: The company's revenue segments are not specified in the provided text.

Insider Ownership: 14.2%

Formycon AG is positioned for significant growth, with earnings expected to rise 74.99% annually as it transitions to profitability within three years. Despite a recent net loss of €125.67 million, Formycon's biosimilar products, like FYB202 and FYB203, have gained regulatory approvals across key markets including the U.S. and Europe. The company's strategic partnerships enhance its market reach in ophthalmology and immunology sectors, although revenue growth forecasts remain below 20% per year at 18%.

• Delve into the full analysis future growth report here for a deeper understanding of Formycon.
• Upon reviewing our latest valuation report, Formycon's share price might be too optimistic.

Make It Happen

• Click this link to deep-dive into the 239 companies within our Fast Growing European Companies With High Insider Ownership screener.
• Want To Explore Some Alternatives? Trump has pledged to "unleash" American oil and gas and these 20 US stocks have developments that are poised to benefit.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com